tiprankstipranks
Perspective Therapeutics says first patient dosed in Phase 1/2a trial of VMT01
PremiumThe FlyPerspective Therapeutics says first patient dosed in Phase 1/2a trial of VMT01
11d ago
Perspective Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Perspective Therapeutics initiated with a Buy at H.C. Wainwright
15d ago
Perspective Therapeutics initiated with a Buy at Brookline
Premium
The Fly
Perspective Therapeutics initiated with a Buy at Brookline
18d ago
Perspective Therapeutics provides business updates, strategic priorities
PremiumThe FlyPerspective Therapeutics provides business updates, strategic priorities
2M ago
Perspective Therapeutics Appoints New Chief Financial Officer
Premium
Company Announcements
Perspective Therapeutics Appoints New Chief Financial Officer
3M ago
Perspective Therapeutics appoints Graham as CFO
Premium
The Fly
Perspective Therapeutics appoints Graham as CFO
3M ago
Perspective Therapeutics price target lowered to $16 from $22 at Oppenheimer
PremiumThe FlyPerspective Therapeutics price target lowered to $16 from $22 at Oppenheimer
4M ago
Perspective Therapeutics selloff a buying opportunity, says JonesResearch
Premium
The Fly
Perspective Therapeutics selloff a buying opportunity, says JonesResearch
4M ago
Perspective Therapeutics Inc trading resumes
Premium
The Fly
Perspective Therapeutics Inc trading resumes
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100